肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2017 AAOOP共识报告：视网膜母细胞瘤风险儿童筛查

2017-10-18 美国眼科肿瘤和病理学家协会 Ophthalmology. 2017 Oct 18.

视网膜母细胞瘤儿童筛查

2017年10月，美国眼科肿瘤和病理学家协会(AAOOP)发布了视网膜母细胞瘤风险儿童筛查共识。风险分层包括基因检测和资讯服务是视网膜母细胞瘤风险儿童筛查的基础。文章主要针对视网膜母细胞瘤风险儿童的筛查提供指导建议。

中文标题：

2017 AAOOP共识报告：视网膜母细胞瘤风险儿童筛查

英文标题：

Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists.

发布机构：

美国眼科肿瘤和病理学家协会

发布日期：

2017-10-18

简要介绍：

2017年10月，美国眼科肿瘤和病理学家协会(AAOOP)发布了视网膜母细胞瘤风险儿童筛查共识。风险分层包括基因检测和资讯服务是视网膜母细胞瘤风险儿童筛查的基础。文章主要针对视网膜母细胞瘤风险儿童的筛查提供指导建议。

 

拓展指南：与视网膜相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 AAOOP共识报告：视网膜母细胞瘤风险儿童筛查)] GetToolGuiderByIdResponse(projectId=1, id=8644a1c001513159, title=2017 AAOOP共识报告：视网膜母细胞瘤风险儿童筛查, enTitle=Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists., guiderFrom=Ophthalmology. 2017 Oct 18., authorId=null, author=, summary=2017年10月，美国眼科肿瘤和病理学家协会(AAOOP)发布了视网膜母细胞瘤风险儿童筛查共识。风险分层包括基因检测和资讯服务是视网膜母细胞瘤风险儿童筛查的基础。文章主要针对视网膜母细胞瘤风险儿童的筛查提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=1538, associationName=美国眼科肿瘤和病理学家协会, associationIntro=, copyright=0, guiderPublishedTime=Wed Oct 18 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年10月，美国眼科肿瘤和病理学家协会(AAOOP)发布了视网膜母细胞瘤风险儿童筛查共识。风险分层包括基因检测和资讯服务是视网膜母细胞瘤风险儿童筛查的基础。文章主要针对视网膜母细胞瘤风险儿童的筛查提供指导建议。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>视网膜</FONT>相关指南：</STRONG><BR> <UL> <LI><A title="2017 SED/SERV共识指南：糖尿病视网膜病变的诊断和治疗（更新版）" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=989af1c001a855e9">2017 SED/SERV共识指南：糖尿病视网膜病变的诊断和治疗（更新版）</A> <LI><A title="2017 ADA立场声明：糖尿病视网膜病变" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=e4bef1c0013e321c">2017 ADA立场声明：糖尿病视网膜病变</A> <LI><A title=选择性眼动脉化疗术治疗视网膜母细胞瘤中国专家共识 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=519c51c0013a342b">选择性眼动脉化疗术治疗视网膜母细胞瘤中国专家共识</A> <LI><A title="2016 AAO临床指南：视网膜及眼动脉阻塞" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=50d951c00131a0da">2016 AAO临床指南：视网膜及眼动脉阻塞</A> <LI><A title=我国早产儿视网膜病变筛查指南（2014年） target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=448a11c0011318de">我国早产儿视网膜病变筛查指南（2014年）</A> 更多信息请点击：<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E8%A7%86%E7%BD%91%E8%86%9C">有关视网膜更多指南</A></LI></UL>, tagList=[TagDto(tagId=9023, tagName=视网膜母细胞瘤), TagDto(tagId=62089, tagName=儿童筛查)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5627, appHits=171, showAppHits=0, pcHits=4512, showPcHits=1495, likes=115, shares=9, comments=15, approvalStatus=1, publishedTime=Sun Oct 29 22:15:33 CST 2017, publishedTimeString=2017-10-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Oct 29 22:15:33 CST 2017, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 10:54:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 AAOOP共识报告：视网膜母细胞瘤风险儿童筛查)])
2017 AAOOP共识报告：视网膜母细胞瘤风险儿童筛查
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=259423, encodeId=7e6225942337, content=好好好 下载 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Tue Nov 07 09:41:45 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259208, encodeId=f7ac259208f5, content=好好好 学习 学习 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Mon Nov 06 18:14:04 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258248, encodeId=d6e9258248db, content=好好好学习学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Fri Nov 03 06:44:01 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257826, encodeId=a8d725e8261a, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Nov 01 17:01:37 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257380, encodeId=062925e3809f, content=阅读.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Oct 31 06:33:11 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-11-07 zwjnj2

    好好好 下载 学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=259423, encodeId=7e6225942337, content=好好好 下载 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Tue Nov 07 09:41:45 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259208, encodeId=f7ac259208f5, content=好好好 学习 学习 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Mon Nov 06 18:14:04 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258248, encodeId=d6e9258248db, content=好好好学习学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Fri Nov 03 06:44:01 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257826, encodeId=a8d725e8261a, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Nov 01 17:01:37 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257380, encodeId=062925e3809f, content=阅读.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Oct 31 06:33:11 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-11-06 zwjnj2

    好好好 学习 学习 学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=259423, encodeId=7e6225942337, content=好好好 下载 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Tue Nov 07 09:41:45 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259208, encodeId=f7ac259208f5, content=好好好 学习 学习 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Mon Nov 06 18:14:04 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258248, encodeId=d6e9258248db, content=好好好学习学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Fri Nov 03 06:44:01 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257826, encodeId=a8d725e8261a, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Nov 01 17:01:37 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257380, encodeId=062925e3809f, content=阅读.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Oct 31 06:33:11 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-11-03 zwjnj2

    好好好学习学习天天向上

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=259423, encodeId=7e6225942337, content=好好好 下载 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Tue Nov 07 09:41:45 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259208, encodeId=f7ac259208f5, content=好好好 学习 学习 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Mon Nov 06 18:14:04 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258248, encodeId=d6e9258248db, content=好好好学习学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Fri Nov 03 06:44:01 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257826, encodeId=a8d725e8261a, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Nov 01 17:01:37 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257380, encodeId=062925e3809f, content=阅读.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Oct 31 06:33:11 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-11-01 1dd8c52fm63(暂无匿称)

    学习学习.了解了解

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=259423, encodeId=7e6225942337, content=好好好 下载 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Tue Nov 07 09:41:45 CST 2017, time=2017-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259208, encodeId=f7ac259208f5, content=好好好 学习 学习 学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Mon Nov 06 18:14:04 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=258248, encodeId=d6e9258248db, content=好好好学习学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Fri Nov 03 06:44:01 CST 2017, time=2017-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257826, encodeId=a8d725e8261a, content=学习学习.了解了解, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Nov 01 17:01:37 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257380, encodeId=062925e3809f, content=阅读.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Oct 31 06:33:11 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-10-31 刘煜

    阅读.谢谢分享

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

选择性眼动脉化疗术治疗视网膜母细胞瘤中国专家共识

暂未更新 · 2016-08-30